Profile
Sarah Mathieson, formerly the Chief Executive Officer of The Research Autism Information Service, Vice President-Corporate Communications at Adamas Pharmaceuticals LLC, Global Head-Communications & Engagement at GSK Plc, and Head-Communications at Pfizer Ltd., also served as the Senior Vice President-Corporate Affairs at Eiger BioPharmaceuticals, Inc. from 2022 to 2023.
Former positions of Sarah Mathieson
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Corporate Officer/Principal | 01/03/2023 |
| ADAMAS PHARMACEUTICALS, INC. | Public Communications Contact | 24/11/2021 |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Public Communications Contact | - |
| GSK PLC | Public Communications Contact | - |
The Research Autism Information Service
The Research Autism Information Service Miscellaneous Commercial ServicesCommercial Services Provides autism information services | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pfizer Ltd.
Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines, vaccines & pharmaceutical products | Health Technology |
The Research Autism Information Service
The Research Autism Information Service Miscellaneous Commercial ServicesCommercial Services Provides autism information services | Commercial Services |
Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
- Stock Market
- Insiders
- Sarah Mathieson
















